SS Innovations International, Inc. (SSII)
NASDAQ: SSII · Real-Time Price · USD
4.670
-0.160 (-3.31%)
Feb 23, 2026, 10:24 AM EST - Market open

Company Description

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India and internationally.

It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.

The company also develops NADI – Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya – XR Pre-Operative Simulator, a robotic surgery platform; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa – Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device.

In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools.

Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products.

Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring services.

The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

SS Innovations International, Inc.
SS Innovations International logo
CountryIndia
IndustryMedical Devices
SectorHealthcare
Employees378
CEOSudhir Srivastava

Contact Details

Address:
405, iLabs Info Technology Centre, 3rd Floor
Gurugram, 122016
India
Phone91 73 3755 3469
Websitessinnovations.com

Stock Details

Ticker SymbolSSII
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001676163
CUSIP Number05453U203
ISIN NumberUS05453U2033
Employer ID47-3478854
SIC Code3841

Key Executives

NamePosition
Dr. Vishwajyoti P. Srivastava M.D.Chief Executive Officer of APAC and Director
Dr. Sudhir Prem Srivastava M.D.Founder, Chief Executive Officer and Chairman
Barry F. CohenChief Operating Officer of Americas and Director
Milan Rao BE, MBAGlobal Chief Operating Officer and Chief Financial Officer
Amit GargManager of Finance and Accounts

Latest SEC Filings

DateTypeTitle
Feb 2, 2026S-1General form for registration of securities under the Securities Act of 1933
Jan 13, 20268-KCurrent Report
Jan 8, 20268-KCurrent Report
Jan 6, 20268-KCurrent Report
Dec 16, 20258-KCurrent Report
Dec 8, 20258-KCurrent Report
Dec 1, 2025DRS[Cover] Draft Registration Statement
Nov 6, 20258-KCurrent Report
Nov 6, 20258-KCurrent Report
Oct 28, 20258-KCurrent Report